-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, kItZDQx3AcViqb46io3R51xVqrL/b2eqhMsoQ40++zVuz1806gP2MB84xd9WusHd khg4NOJjSKW+8dfvZ0I6eA== 0000950123-95-000215.txt : 19950501 0000950123-95-000215.hdr.sgml : 19950501 ACCESSION NUMBER: 0000950123-95-000215 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19950207 SROS: AMEX SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENOVESE DRUG STORES INC CENTRAL INDEX KEY: 0000040970 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 111556812 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-38263 FILM NUMBER: 95505922 BUSINESS ADDRESS: STREET 1: 80 MARCUS DR CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 5164201900X216 MAIL ADDRESS: STREET 1: 3500 ONE PEACHTREE CENTER STREET 2: 303 PEACHTREE ST NE CITY: ATLANTA STATE: GA ZIP: 30308 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WANGBERG FRANCIS GENOVESE CENTRAL INDEX KEY: 0000918835 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 136865387 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 3500 ONE PEACHTREE CENTER STREET 2: 303 PEACHTREE STREET NE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 4045818542 MAIL ADDRESS: STREET 1: CAMILLE C DUEERR STREET 2: 3500 ONE PEACHTREE CENTER, 303 PEACHTREE CITY: MELVILLE STATE: NY ZIP: 11747 SC 13G 1 SCHEDULE 13G OF FRANCES GENOVESE WANGBERG 1 --------------------------- OMB APPROVAL --------------------------- UNITED STATES OMB Number: 3235-0145 SECURITIES AND EXCHANGE COMMISSION Expires: October 31, 1994 Washington, D.C. 20549 Estimated average burden hours per response... 14.90 --------------------------- SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ______________)*
GENOVESE DRUG STORES, INC. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $1.00 PER SHARE (Title of Class of Securities) 372442202 (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). - ------------------------------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages 2 CUSIP No. 372442202 13G Page 2 of 5 Pages ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS Frances Genovese Wangberg ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America ________________________________________________________________________________ NUMBER OF 5 SOLE VOTING POWER SHARES 1,710,003 ________________________________________________________ BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 0 ________________________________________________________ EACH 7 SOLE DISPOSITIVE POWER REPORTING 1,710,003 ________________________________________________________ PERSON WITH 8 SHARED DISPOSITIVE POWER 0 ________________________________________________________________________________ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,710,003 ________________________________________________________________________________ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / ________________________________________________________________________________ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 25.8% ________________________________________________________________________________ 12 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 5 pages 3 ITEM 1(a). NAME OF ISSUER: Genovese Drug Stores, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 80 Marcus Drive Melville, NY 11747 ITEM 2(a). NAME OF PERSON FILING: Frances Genovese Wangberg ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 80 Marcus Drive Melville, NY 11747 ITEM 2(c). CITIZENSHIP: United States of America ITEM 2(d). TITLE OF CLASS OF SECURITIES: Class A Common Stock, par value $1.00 per share ITEM 2(e). CUSIP NUMBER: 372442202 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: Not applicable ITEM 4. OWNERSHIP. (a) AMOUNT BENEFICIALLY OWNED: 1,710,003 (b) PERCENT OF CLASS: 25.8% (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) SOLE POWER TO VOTE OR TO DIRECT THE VOTE 1,710,003 (ii) SHARED POWER TO VOTE OR TO DIRECT THE VOTE 0 (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 1,710,003 Page 3 of 5 pages 4 (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable ITEM 10. CERTIFICATION. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 7, 1995 ---------------------------------------- (Date) /s/ Frances Genovese Wangberg ---------------------------------------- (Signature) Frances Genovese Wangberg ---------------------------------------- (Name/Title) Page 4 of 5 pages 5 ANNEX A TO SCHEDULE 13G OF FRANCES GENOVESE WANGBERG The aggregate number of shares shown as beneficially owned by the Reporting Person includes the effect of a 10% stock dividend paid in January 1995. Of the aggregate number of shares shown as beneficially owned by the Reporting Person, 1,695,562 are beneficially owned in the form of the Issuer's Class B Common Stock, par value $1.00 per share, which class is not registered as a class of equity securities under the Securities Act of 1933, and 11,784 are owned in the form of options exercisable for shares of the Issuer's Class A Common Stock, all of which can be converted within 60 days into an equal number of shares of the Issuer's Class A Common Stock. Of such number of shares of the Issuer's Class B Common Stock, 1,431,686 are beneficially owned as Trustee under the Trust under the Will of the late Joseph W. Genovese, Jr. and the Reporting Person is the sole beneficiary of such trust. Page 5 of 5 pages -----END PRIVACY-ENHANCED MESSAGE-----